Actavis Pharma, Inc. has received approval for its generic version of minocycline hydrochloride (ANDA063181), a timely move that increases competition and may limit pricing pressure within the oral antibiotic market.
Actavis Pharma, Inc. has received approval for its generic version of minocycline hydrochloride (ANDA063181), a timely move that increases competition and may limit pricing pressure within the oral antibiotic market.